NasdaqCM - Delayed Quote USD
Rein Therapeutics Inc. (RNTX)
1.7600
+0.0200
+(1.15%)
At close: May 9 at 4:00:00 PM EDT
1.7600
0.00
(0.00%)
After hours: May 9 at 4:05:07 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.28 | -0.17 | -0.69 | -0.54 |
| Low Estimate | -0.28 | -0.17 | -0.69 | -0.54 |
| High Estimate | -0.28 | -0.17 | -0.69 | -0.54 |
| Year Ago EPS | -- | -0.45 | -1.49 | -0.69 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.02 | -0.42 | -0.45 | -0.48 |
| EPS Actual | -0.86 | -0.45 | -0.27 | -0.26 |
| Difference | 0.16 | -0.03 | 0.18 | 0.22 |
| Surprise % | 15.69% | -7.14% | 40.00% | 45.56% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.28 | -0.17 | -0.69 | -0.54 |
| 7 Days Ago | 0 | 0 | -1.88 | -1.78 |
| 30 Days Ago | 0 | 0 | -1.88 | -1.78 |
| 60 Days Ago | 0 | 0 | -1.88 | -1.78 |
| 90 Days Ago | 0 | 0 | -1.88 | -1.78 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RNTX | -- | 62.22% | 53.76% | 21.74% |
| S&P 500 | 13.21% | 3.09% | 8.02% | 13.76% |
Related Tickers
ACTU Actuate Therapeutics, Inc. Common stock
10.35
+4.55%
RNXT RenovoRx, Inc.
1.0600
+1.92%
CUE Cue Biopharma, Inc.
0.7797
+1.52%
COYA Coya Therapeutics, Inc.
6.05
-2.58%
INAB IN8bio, Inc.
0.1574
-6.25%
NMTRQ 9 Meters Biopharma, Inc.
0.0001
0.00%
4565.T Nxera Pharma Co., Ltd.
876.00
-0.23%
4587.T PeptiDream Inc.
1,916.50
+1.16%
APS.TO Aptose Biosciences Inc.
2.2100
-0.45%
APTOF Aptose Biosciences Inc.
1.6500
0.00%